|
|
It’s exciting to see that home-grown post-pandemic recovery seems to be the flavour of the month in the media, and that the home in question has firm foundations in BC. Business in Vancouver notes federal funding for Symvivo’s oral COVID-19 vaccine development and also celebrates Precision Nanosystem’s earlier award to develop a made-in-Canada vaccine facility
In Victoria, federal funding announced on Tuesday will support creation of the Centre for Advanced Materials & Related Technology (CAMTEC) BioMedical Core at the University of Victoria. Open to a broad range of users, the facility should help overcome some of the obstacles — namely space and specialized equipment —that currently limit the ability to scale up. |
|
On the weekend, the Vancouver Sun celebrated the recent 2020 Capital Market Report from the BC Securities Commission, which shows $2.3 billion raised by the BC biotech sector. This translates as a 123 per cent increase, with the majority raised by Life Sciences BC members AbCellera Biologics, Zymeworks, Aurinia Pharmaceuticals, and Xenon Pharmaceuticals.
Congratulations to all for this wonderful news!
LSBC Members On the Move and In the News
Congratulations to Axolotl Biosciences who shared that they have advanced to Round 3 of the New Ventures BC competition. You can also hear CEO Stephanie Willerth talk about 3D printing with BioInks in the MedTalkcracy podcast linked from this tweet.
We’d also like to welcome Novartis into the Gold tier of sponsorship with us, and give a shout out to new member, PicoQuant who will be in Vancouver next week, answering your questions on field of time-resolved imaging (details below).
|
|
|
|
Last Week for Applications for the Investor Readiness Program! |
Are you a B.C SME in the life sciences industry? Looking to learn and get experience in pitching for potential investors? Become investor-ready with LSBC’s Investor Readiness Program!
A unique 7-month program designed around individual coaching, drawing on the expertise and acumen of experienced life science professionals to mentor specifically on investor readiness for early-stage life sciences SMEs. Complemented by educational sessions, goal setting, peer-to-peer feedback, conference opportunities and group meetings, the program culminates with an investor pitch session where participants use their new skills to pitch to a group of pre-qualified investors. Apply here
For questions regarding the program, please contact William Burrows, Director of Business &Operations
|
|
|
|
Our annual magazine, Life Sciences 2021, in production with Business in Vancouver, hits the stands in late September to coincide with our annual Awards ceremony. The deadline for an ad buy is August 11; further details and a media kit are available.
Please contact Laura Torrance, Sales Manager with BIV on 604-608-5145 or ltorrance@biv.com.
|
|
|
|
PENTICTON, BC – XCO Tech Inc. (XCO) today announced it is receiving advisory services and funding of up to $1M from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) over three years to advance research and development of embedded AI-based technologies for chronic disease assessment and monitoring. READ MORE
|
|
|
|
Don’t miss the opportunity to meet with PicoQuant’s application specialist in Canada, Dr. Linnea Olofsson, who will be in Vancouver the week of July 25th to present recent major developments in the field of time-resolved imaging (rapidFLIM, FRET-FLIM) as well as cutting-edge technologies for single-molecule detection (smFRET) and Fluorescence Correlation Spectroscopy (FCS, FCCS, FLCS). PicoQuant offers various instruments ranging from LSM upgrade kits compatible with most major LSM companies such as Nikon, Zeiss and Olympus, in addition to their own microscopy line including the uniquely designed MT200 – the most sensitive microscope on the market.
If you are interested in knowing more about how you can unlock a completely new dimension of quantitative information, and access Picoquant’s wealth of knowledge acquired over 25 years of experience in the field of time-resolved microscopy, please contact Linnea directly to set up a meeting at linnea.olofsson@picoquant-usa.com or call her at (438) 407-6441.
|
|
|
|
Axolotl Biosciences' CEO, Stephanie Willerth was featured in a podcast on 3D Bio-Printing with Medtalkcracy.
|
|
|
|
Burnaby-based Symvivo Corporation announced Monday the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) is earmarking $4.6 million to support the clinical advancement of the company’s vaccine candidate known as bacTRL-Spike. READ MORE
|
|
|
|
VANCOUVER, B.C. – iCo Therapeutics Inc. (“iCo” or the “Company”) is pleased to announce that the Company has received formal conditional approval from the TSX Venture Exchange (the “Exchange”) of iCo’s proposed business combination (the “Transaction”) with Satellos Bioscience Inc. (“Satellos”). READ MORE
|
|
|
|
NEW YORK & MAINZ, Germany– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as “Biovac,” a Cape Town-based, South African biopharmaceutical company, to manufacture the Pfizer-BioNTech COVID-19 Vaccine for distribution within the African Union. READ MORE
|
|
|
|
OTTAWA, ON – BioTalent Canada announced the continuation of its Science and Technology Internship Program – Green Jobs (STIP) wage subsidy. This program—funded in part by Natural Resources Canada—further supports a vibrant green economy essential to Canada’s sustainability. The $3.7M in funding will help to replenish the one resource the sector needs to thrive: young, skilled talent.
|
|
|
|
St. Paul’s Foundation welcomes Nicole Coleman, Audit Partner at Deloitte, and Karimah Es Sabbar, Chief Executive Officer & Partner at Quark Venture to our Board of Directors. READ MORE
|
|
|
|
VGH and UBC hospital foundation is pleased to announce the appointment of two new members to our Board of Directors, Chief Ian Campbell, the first Indigenous member of the Foundation's Board of Directors and Dr. David Granville, Executive Director of Vancouver Coastal Health Research Institute (VCHRI). READ MORE
|
|
|
|
VICTORIA, BC, /CNW/ – British Columbia’s life sciences sector has faced substantial equipment and training costs, restricting companies from quickly responding to challenges such as the COVID-19 pandemic. Opportunities exist to improve the health of western Canadians, which is why the Government of Canada is investing in access to critical infrastructure and training in this sector. READ MORE
|
|
|
|
Exciting news...applications for entrepreneurship@UBC’s Lab2Launch Venture Building Program are open! As part of Lab2Launch, you have an opportunity to join their Social Venture, Human Health Venture and Climate Venture Studios for additional industry-specific programming and community. Check out which program is right for you on their website and apply by August 3! Apply here
|
|
 |
Headquartered in Vancouver, Axis Insurance Group serves both domestic and international clients with risk management and insurance services. Backed by a team of insurance professionals, they have built a reputation as industry leaders with the specialty knowledge and skill to best serve their clients.Their vast portfolio includes providing customized insurance solutions for clients in industries such as mining, construction, professional and financial services, manufacturing, life sciences, and technology.
|
|
|
|
SaNOtize Research and Development Corp., is a rapidly growing pharmaceutical company focused on developing and commercializing high quality, innovative products. SaNOtize aim to improve the quality of life for people throughout the world using their proprietary biotechnology platform to remedy topical infections that negatively impact quality of life. Therapeutic targets include SARS-COV-2 (COVID-19), influenza, onychomycosis (nail fungus), chronic sinusitis, diabetic foot ulcers and others.
|
|
|
|
|
|
PERSPECTIVES ON GLOBAL HEALTHCARE INNOVATION |
What’s driving innovation in life science and healthcare? SVB is committed to serving the ecosystem by providing industry-leading reports featuring proprietary analysis and targeted outlooks to help companies and investors achieve their goals. Twice a year we publish deep-dive analyses describing fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank. To find out more about Silicon Valley Bank click here
|
|
|
|
Posting A Job on the LSBC Website |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? CONTACT: Peter McLoughlin - talent@lifesciencesbc.ca
|
|
|
|
|
|
|
